ID: ALA363352

Max Phase: Preclinical

Molecular Formula: C17H17ClN2O3S

Molecular Weight: 364.85

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC/C=C\COC1(c2ccc(Cl)cc2)SC=C(C)n2c1noc2=O

Standard InChI:  InChI=1S/C17H17ClN2O3S/c1-3-4-5-10-22-17(13-6-8-14(18)9-7-13)15-19-23-16(21)20(15)12(2)11-24-17/h4-9,11H,3,10H2,1-2H3/b5-4-

Standard InChI Key:  FHQCBTSYENFAFR-PLNGDYQASA-N

Associated Targets(Human)

A2780 11979 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P-glycoprotein 1 14716 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Multidrug resistance-associated protein 6 18 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Acetylcholinesterase 18204 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HEK293 82097 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 364.85Molecular Weight (Monoisotopic): 364.0648AlogP: 4.24#Rotatable Bonds: 5
Polar Surface Area: 57.26Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.94CX LogD: 4.94
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: -0.40

References

1. Budriesi R, Carosati E, Chiarini A, Cosimelli B, Cruciani G, Ioan P, Spinelli D, Spisani R..  (2005)  A new class of selective myocardial calcium channel modulators. 2. Role of the acetal chain in oxadiazol-3-one derivatives.,  48  (7): [PMID:15801835] [10.1021/jm0493414]
2. Viale M, Cordazzo C, Cosimelli B, de Totero D, Castagnola P, Aiello C, Severi E, Petrillo G, Cianfriglia M, Spinelli D..  (2009)  Inhibition of MDR1 activity in vitro by a novel class of diltiazem analogues: toward new candidates.,  52  (2): [PMID:19093883] [10.1021/jm801195k]
3. Rosano C, Viale M, Cosimelli B, Severi E, Gangemi R, Ciogli A, De Totero D, Spinelli D..  (2013)  ABCB1 Structural Models, Molecular Docking, and Synthesis of New Oxadiazolothiazin-3-one Inhibitors.,  (8): [PMID:24900735] [10.1021/ml300436x]
4. Cuviello F, Bisaccia F, Spinelli D, Armentano MF, Bufo SA, Cosimelli B, Ostuni A..  (2019)  The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation.,  164  [PMID:30583246] [10.1016/j.ejmech.2018.12.037]

Source